Determination of Synthetic Lethal Interactions in KRAS Oncogene-Dependent Cancer Cells Reveals Novel Therapeutic Targeting Strategies

Cell Research - United States
doi 10.1038/cr.2012.82
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Therapeutic Strategies for Targeting Cancer Stem Cells

Journal of Cancer Metastasis and Treatment
2016English

Novel Therapeutic Strategies for Ovarian Cancer Stem Cells

Frontiers in Oncology
Cancer ResearchOncology
2020English

Targeting KRAS Oncogene in Colon Cancer Cells With 7-Carboxylate Indolo[3,2-B]quinoline Tri-Alkylamine Derivatives

PLoS ONE
Multidisciplinary
2015English

Synthetic Lethal Interactions Between EGFR and PARP Inhibition in Human Triple Negative Breast Cancer Cells

PLoS ONE
Multidisciplinary
2012English

KRAS-Driven Metabolic Rewiring Reveals Novel Actionable Targets in Cancer

Frontiers in Oncology
Cancer ResearchOncology
2019English

Therapeutic Development in Targeting Protein–protein Interactions With Synthetic Topological Mimetics

Current Opinion in Pharmacology
Drug DiscoveryPharmacology
2012English

Synthetic Lethal Interaction of Combined BCL-XL and MEK Inhibition Promotes Tumor Regressions in KRAS Mutant Cancer Models

Cancer Cell
Cancer ResearchOncologyCell Biology
2013English

Correction: CDK1 Is a Synthetic Lethal Target for KRAS Mutant Tumours

PLoS ONE
Multidisciplinary
2016English

Therapeutic Targeting of Non-Oncogene Dependencies in High-Risk Neuroblastoma

Clinical Cancer Research
Cancer ResearchOncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy